Cardiovascular prevention model from Kenyan slums to migrants in the Netherlands

被引:6
|
作者
van de Vijver, Steven [1 ,2 ]
Oti, Samuel [1 ,2 ]
van Charante, Eric Moll [3 ]
Allender, Steven [4 ]
Foster, Charlie [5 ]
Lange, Joep [1 ]
Oldenburg, Brian [6 ]
Kyobutungi, Catherine [1 ]
Agyemang, Charles [7 ]
机构
[1] African Populat & Hlth Res Ctr, Nairobi, Kenya
[2] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Family Med, NL-1105 AZ Amsterdam, Netherlands
[4] Deakin Univ, Dept Publ Hlth, Melbourne, Vic, Australia
[5] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England
[6] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia
[7] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands
关键词
Reverse innovation; Hypertension; Prevention; Treatment; Slums; Kenya; African migrants; HYPERTENSION; DISEASE; NAIROBI; AFRICA; PREVALENCE; AWARENESS; GHANAIAN; OBESITY;
D O I
10.1186/s12992-015-0095-y
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Cardiovascular diseases (CVD) are the main cause of morbidity and mortality worldwide. As prevention and treatment of CVD often requires active screening and lifelong follow up it is a challenge for health systems both in high-income and low and middle-income countries to deliver adequate care to those in need, with efficient use of resources. We developed a health service model for primary prevention of CVD suitable for implementation in the Nairobi slums, based on best practices from public health and the private sectors. The model consists of four key intervention elements focusing on increasing awareness, incentives for promoting access to screening and treatment, and improvement of long-term adherence to prescribed medications. More than 5,000 slum dwellers aged >= 35 years and above have been screened in the study resulting in more than 1000 diagnosed with hypertension and referred to the clinic. Some marginalized groups in high-income countries like African migrants in the Netherlands also have low rates of awareness, treatment and control of hypertension as the slum population in Nairobi. The parallel between both groups is that they have a combination of risky lifestyle, are prone to chronic diseases such as hypertension, have limited knowledge about hypertension and its complications, and a tendency to stay away from clinics partly due to cultural beliefs in alternative forms of treatment, and lack of trust in health providers. Based on these similarities it was suggested by several policymakers that the model from Nairobi can be applied to other vulnerable populations such as African migrants in high-income countries. The model can be contextualized to the local situation by adapting the key steps of the model to the local settings. The involvement and support of African communities' infrastructures and health care staff is crucial, and the most important enabler for successful implementation of the model in migrant communities in high-income countries. Once these stakeholders have expressed their interest, the impact of the adapted intervention can be measured through an implementation research approach including collection of costs from health care providers' perspective and health effects in the target population, similar to the study design for Nairobi.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] A community-based intervention for primary prevention of cardiovascular diseases in the slums of Nairobi: the SCALE UP study protocol for a prospective quasi-experimental community-based trial
    Samuel O Oti
    Steven JM van de Vijver
    Catherine Kyobutungi
    Gabriela B Gomez
    Charles Agyemang
    Eric P Moll van Charante
    Lizzy M Brewster
    Marleen E Hendriks
    Constance Schultsz
    Remare Ettarh
    Alex Ezeh
    Joep Lange
    Trials, 14
  • [22] Screening and prevention of infectious diseases in newly arrived migrants. Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015
    Bil, Janneke P.
    Schrooders, Peter A. G.
    Prins, Maria
    Kouw, Peter M.
    Klomp, Judith H. E.
    Scholing, Maarten
    Huijbregts, Lutje P. H. M.
    Sonder, Gerard J. B.
    Waegemaekers, Toos C. H. F. M.
    de Vries, Henry J. C.
    Meijer, Wieneke
    Zuure, Freke R.
    Tostmann, Alma
    EUROSURVEILLANCE, 2018, 23 (11) : 24 - 32
  • [23] Contribution of short sleep duration to ethnic differences in cardiovascular disease: results from a cohort study in the Netherlands
    Anujuo, Kenneth
    Agyemang, Charles
    Snijder, Marieke B.
    Jean-Louis, Girardin
    van den Born, Bert-Jan
    Peters, Ron J. G.
    Stronks, Karien
    BMJ OPEN, 2017, 7 (11):
  • [24] Pathways leading to prevention of fatal and non-fatal cardiovascular disease: An interaction model on 15 years population-based cohort study
    Shakibaei, Najmeh
    Hassannejad, Razieh
    Mohammadifard, Noushin
    Marateb, Hamid Reza
    Mansourian, Marjan
    Mananas, Miguel Angel
    Sarrafzadegan, Nizal
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)
  • [25] Potential cardiovascular consequences of switching from atorvastatin to generic simvastatin in the Netherlands
    Liew, D.
    Webb, K.
    Meerding, W. -J.
    Buskens, E.
    Jukema, J. W.
    NETHERLANDS HEART JOURNAL, 2012, 20 (05) : 197 - 201
  • [26] Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands
    Li, Xuechun
    Bijlsma, Maarten J.
    Bos, Jens H. J.
    Schuiling-Veninga, Catharina C. M.
    Hak, Eelko
    BMJ OPEN, 2023, 13 (08):
  • [27] Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling Study
    Smit, Mikaela
    van Zoest, Rosan A.
    Nichols, Brooke E.
    Vaartjes, Ilonca
    Smit, Colette
    van der Valk, Marc
    van Sighem, Ard
    Wit, Ferdinand W.
    Hallett, Timothy B.
    Reiss, Peter
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (05) : 743 - 750
  • [28] Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands
    Li, Xuechun
    Bijlsma, Maarten J.
    Bos, Jens H. J.
    Schuiling-Veninga, Catharina C. M.
    Hak, Eelko
    BMJ OPEN, 2023, 13 (03):
  • [29] Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention
    Nilsson, Peter M.
    Boutouyrie, Pierre
    Cunha, Pedro
    Kotsis, Vasilios
    Narkiewicz, Krzysztof
    Parati, Gianfranco
    Rietzschel, Ernst
    Scuteri, Angelo
    Laurent, Stephane
    JOURNAL OF HYPERTENSION, 2013, 31 (08) : 1517 - 1526
  • [30] Cardiovascular Prevention: Migrating From a Binary to a Ternary Classification
    Doneen, Amy Lynn
    Bale, Bradley Field
    Vigerust, David John
    Leimgruber, Pierre P.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7